Trinity Biotech | TRIB - Gross Profit On Sales

Stock Price
0.79
Daily Change
0.08 11.72%
Monthly
4.55%
Yearly
-4.56%
Q1 Forecast
0.79

Trinity Biotech reported $6.47M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
Bio-Rad Laboratories USD 345.3M 34.7M Jun/2025
EDAP TMS EUR 6.82M 1.13M Jun/2025
J&J USD 16.6B 118M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Siemens EUR 7.54B 132M Jun/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Tosoh JPY 67.57B 10.89B Sep/2025
Trinity Biotech USD 6.47M 1.59M Sep/2025
Veracyte USD 91.28M 1.51M Sep/2025